Suspended the EEA, note here Expired which one applies Withdrawn 1 the date of the most recent change to the licence status: eg date of approval or date of suspension A3.2 Licensing status in the rest of the Country Current Date of licence Date first Brand name(s) Comments licence status action 1 marketed in country Choose one of <Enter a date> <Enter a date> the following: Approved Refused Under review Suspended Expired Withdrawn Annex 4 - Synopsis of on-going and completed clinical programme Description (Phase, Countries Study Duration Study short description of design number of of follow study (1 2 patients up completion – sentences including date comparator name(s)/placebo)) Main or pivotal studies
Suspended Expired Withdrawn the EEA, note here which one applies 1 the date of the most recent change to the licence status: eg date of approval or date of suspension A3.2 Licensing status in the rest of the Country Current licence status Date of licence action 1 Date first marketed in country Brand name(s) Comments Choose one of the following: Approved Refused Under review Suspended Expired Withdrawn <Enter a date> <Enter a date> Annex 4 - Synopsis of on-going and completed clinical programme Study Description (Phase, short description of study (1 – 2 sentences including comparator name(s)/placebo)) Countries Study design number of patients Duration of follow up completion date Main or pivotal studies